MIRA INFORM REPORT

 

 

Report Date :           

03.04.2012

 

IDENTIFICATION DETAILS

 

Name :

RECKITT BENCKISER HEALTHCARE MANUFACTURING [THAILAND] LTD.

 

 

Formerly Known As :

THE  BOOTS  MANUFACTURING CO. [THAILAND]  LTD.

 

 

Registered Office :

65  Moo  12,  Ladkrabang-Bangplee  Road, T. Bangpleeyai,  A.  Bangplee,

Samutprakarn  10540

 

 

Country :

Thailand

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

21.12.1977

 

 

Com. Reg. No.:

0105520018811

 

 

Legal Form :

Private  Limited  Company

 

 

Line of Business :

Manufacturer  & distributor of medical,  pharmaceutical  and household  products

 

 

No. of Employees :

230

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Thailand

b2

b2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name

 

RECKITT BENCKISER HEALTHCARE MANUFACTURING [THAILAND] LTD.

 

[FORMER : THE  BOOTS  MANUFACTURING CO. [THAILAND]  LTD.]

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           65  MOO  12,  LADKRABANG-BANGPLEE  ROAD,

T.       BANGPLEEYAI,  A.  BANGPLEE,

SAMUTPRAKARN  10540,  THAILAND

TELEPHONE                                         :           [66]  2337-3620-8  

FAX                                                      :           [66]  2337-3629-30                    

E-MAIL  ADDRESS                                :           suthep.veerawatananan@bhint.com

REGISTRATION  ADDRESS                  :           SAME  AS  BUSINESS  ADDRESS

 

ESTABLISHED                                     :           1977      

REGISTRATION  NO.                           :           0105520018811  [Former : 1881/2520]      

CAPITAL REGISTERED                         :           BHT.  58,000,000  

CAPITAL PAID-UP                                :           BHT.  58,000,000  

SHAREHOLDER’S  PROPORTION         :           THAI     :      100%

FISCAL YEAR CLOSING DATE              :           DECEMBER  31             

LEGAL  STATUS                                  :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MR.  ATAUR  RASHID  SAFDAR,  INDIAN

                                                                        CHIEF  EXECUTIVE  OFFICER  

 

NO.  OF  STAFF                                   :           230

LINES  OF  BUSINESS                          :           MEDICAL,  PHARMACEUTICAL  AND HOUSEHOLD 

                                                                        PRODUCTS

                                                                        MANUFACTURER  & DISTRIBUTOR 

                                               

                         

CORPORATE PROFILE

 

OPERATING  TREND                            :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                       :           GOOD  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  GOOD  PERFORMANCE                       

 

 

 

 

 


HISTORY

 

The  subject  was established  on   December  21, 1977  as  a  private  limited  company,  under  the  originally  registered  name “The  Boots  Manufacturing  Co.  [Thailand]  Ltd.” by  a  joint  venture  between  Thai  and  British  groups,  in  order  to  manufacture,  import  and  distribute  medical  and  pharmaceutical  and household  products  to  domestic and international markets. 

 

The  subject  was  initially an  affiliated  of  The  Boots  PLC,    United  Kingdom,  which  is  a  member  of  The  Boots  Group,    holding  around  49.00%  of   the  subject’s shares.

 

In  May  2002, Boots  Holding [BHI]  Limited,  United Kingdom,  has  taken  the  subject’s  shares,  then  became  the  major  shareholder  of  the  subject.

 

In  February  2006,  the  subject  has  been  taken  over  by  Reckitt  Benckiser  PLC.,  then  its name was  changed    to  RECKITT  BENCKISER  HEALTHCARE  MANUFACTURING  [THAILAND] LTD.,  on October 17,  2006.  Its  business  became  to  manufacture  and  distribute  pharmaceutical  and  healthcare  products  to  both   domestic and  international  markets.  Its  production  has  been  achieved  the  quality  standard  for  the  production  by  MHRA,  Australian  TGA,  Thai  FDA  and  Tanzania  FDA.

 

Presently, the subject is a wholly owned  subsidiary of Reckitt  Benckiser  Holding [Thailand]  Ltd.  It currently employs  approximate  230  staff.

 

The  subject’s  registered  address  is 65  Moo 12,  Ladkrabang-Bangplee  Rd.,  Bangpleeyai,  Bangplee,  Samutprakarn  10540,  and  this  is  the  subject’s  current  operation  address.

 

 

THE BOARD  OF  DIRECTORS

 

     Name

 

Nationality

Age

 

 

 

 

Mr.  Dimokratis  Tsakiris

 

Greek

48

Mr.  Ataur  Rashid  Safdar

 

Indian

43

Ms.  Ashish  Gupta

 

Indian

35

Ms. Sumitra  Meesuwan

 

Thai

49

Mrs. Kesinee  Valeeitthikul

 

Thai

51

 

AUTHORIZED  PERSON

 

Two  of  the  above  directors  can  jointly  sign  on  behalf  of  the  subject  with  company’s  affixed.

 


MANAGEMENT

 

Mr.  Ataur  Rashid  Safdar  is  the  Chief  Executive  Officer.

He  is  Indian  nationality  with  the  age  of  43  years  old.

 

Mr.  Apichid  Kanokpongphaibul   is  the  Production  Manager.

He  is  Thai  nationality.

 

Mr.  Santi  Kaewpradit  is  the  Account  &  Finance  Manager.

He  is  Thai  nationality.

 

Ms. Ratchaneekorn  Sangkanaporn  is  the  Human  Resources  Manager.

She  is  Thai  nationality.

 

 

BUSINESS OPERATIONS

 

The  subject’s  core business  is  engaged  in  manufacturing and distributing  antiseptic  lozenge  for  the  relief  of  mouth  and  throat  infections  with  added  vitamin  C  under  brand  name  “STREPSILS”,  as  well  as  various  forms  of  pharmaceutical & healthcare  and  household   products.   

 

BRAND  NAMES

“STREPSILS”,  “NUROFEN”,  “BURNOL”,  “TUSSILE”,  “STREPTUSS  AX”,  “DETTOL”,  “AIR WICK”,  “VANISH”  and etc.

 

IMPORT

Raw  materials &  chemicals  are  purchased  from  supplier  both  in  domestic and  overseas,  mainly  in  United Kingdom,  Germany,  New  Zealand,  Japan  and  France.

 

MAJOR  SUPPLIER

Reckitt  Benckiser  Healthcare  Ltd.        :  U.K.

 

SALES  [LOCAL]

100%  of  its  products  is  sold  locally  by  wholesale  to  Reckitt  Benckiser [Thailand]  Ltd.

 

PARENT  COMPANY

Reckitt  Benckiser  Holding [Thailand]  Ltd.

Address:  14th Floor,  K Tower,  209 Sukhumvit  21 Rd.,  Klongtoey  Nua,  Wattana,   

                Bangkok.

 

RELATED/ASSOCIATED  COMPANIES

Reckitt  Benckiser  Healthcare  [Thailand]  Ltd.

Business Type:  Importer & distributor  of  pharmaceutical & healthcare  products

 

Reckitt  Benckiser [Thailand]  Ltd.

Business Type:   Distributor  of  pharmaceutical and  healthcare  products


LITIGATION

 

Bankruptcy  and  Receivership

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

There  are  no  legal  suits  filed  against   the  subject  for  the  past  two  years.

 

CREDIT  

Sales  are  by  cash  or  on  the  credits  term  of   30-60  days.

Local  bills  are  paid   by  cash  or  on  the  credits  term  of   30-60  days.

Imports  are  by  L/C  at  sight  or  T/T.

 

BUSINESS  TRANSACTION

The  products  are  sold  both  by  cash  and  credit  with  given  at  30-60  days.  The  subject  is  not  found  to have   problem  on  its  account  receivable.

 

BANKING

Bangkok  Bank  Public Co.,  Ltd.                    

  [Bangplee  Branch : Bangna-Trad  Rd.,  Km 15,  Bangplee,  Samutprakarn 10540]

 

Kasikornbank  Public  Co., Ltd.          

  [Bangplee  Branch : 68/11-13  Moo 1,  Bangna-Trad  Rd.,  Bangplee,  Samutprakarn 10540]

 

EMPLOYMENT

The  subject  employs  approximately  230  staff  [office  staff   and  factory  workers].

 

LOCATION  DETAILS

The premise is rented  for administrative office, factory and warehouse  at  the heading  address.  Premise  is  located in  industrial  area.

 

REMARK

MAXIMUM  CREDIT  SHOULD  BE  GRANTED  AT  US$  5,000,000.

 

COMMENT

The  company  delivered  another  strong  year,  exceeding  both  its net  sale  target and  net  income  in  an  increasingly  tough  environment.   Growth  was  driven in particular  by  excellent  growth  in emerging  markets,  and  growth in  Powerbrands.  Personal  care was  driven  by  the  continued  to  deliver  an  encourage  result.

 

Its  manufacturing  facility in Thailand primarily manufactures Strepsils.   It  drives  growth across  the household, personal and health care sectors, with several recent new product launches, including Air Wick.   Key brands  also  include Dettol,  and it has enjoyed real success with Powerbrands like Vanish.  The  company  has  recently  increased  net sales  in  Thailand  market.

 


FINANCIAL  INFORMATION

 

The  capital  was  initially  registered  at  Bht. 100,000  divided  into  1,000  shares  of  Bht.      100  each.

 

The  capital  was  increased  later  as  follows:

 

            Bht.    3,000,000  on      July  23,  1997

            Bht.    4,000,000  on      May  26,  2005

            Bht.    8,000,000  on  December  19,  2006

            Bht.  58,000,000  on   November  8,  2011

 

The  latest  registered  capital  was  increased  to  Bht.  58,000,000  divided  into  580,000 shares  of  Bht.  100   each  with  fully  paid.

 

 

THE  SHAREHOLDERS  LISTED  WERE  :   [as  at  October  21,  2011]

       NAME

HOLDING

%

 

 

 

Reckitt  Benckiser Holding [Thailand]  Ltd.

Nationality: Thai

Address    : 14th Floor,  K Tower, 209 Sukhumvit 21 Rd.,

                   Klongton Nua,  Wattana,  Bangkok

579,993

100.00

R & C Nominees  One  Ltd.

Nationality: British

Address    : 103-105 Bath Rode  Slought,  Berkshire, SL 1

                   3 UH,  England

2

-

R & C Nominees  Two  Ltd.

Nationality: British

Address    : 103-105 Bath Rode  Slought,  Berkshire, SL 1

                   3 UH,  England

     2

-

Mr.  Veerasak Inchanteuk

Nationality: Thai

Address    : 41  Sukhumvit 101/11, Bangchak, Prakanong,

                    Bangkok

       1

- 

Mr.  Pairach  Harurawee

Nationality: Thai

Address    : 42/5-6,  Soi   Ngamduplee,  Tungmahamek,

                   Sathorn,  Bangkok  

      1

- 

Mrs.  Wanpen  Harnrawee

Nationality: Thai

Address    : 42/5-6,  Soi   Ngamduplee,  Tungmahamek,

                   Sathorn,  Bangkok  

1

-

 

Total  Shareholders  :   6


 

Share  Structure  [as  at  October  21,  2011]

Nationality

Shareholders

No. of  Share

% Shares

 

 

 

 

Thai

4

579,996

100.00

British

2

4

-

 

Total

 

6

 

580,000

 

100.00

 

NAME  OF  AUDITOR  &  CERTIFIED  PUBLIC   ACCOUNTANT  NO. :

Mr.  Kajornkiat  Aroonpairojkul   No.  3445

 

 

Note

The  2011  financial  statement  was  not  submitted  to  the  Commercial  Registration  Department  during  investigation.

 

 

BALANCE SHEET [BAHT]

 

The  latest  financial figures  published  as  at  December  31,  2010  &  2009  were:

          

ASSETS

                                                                                                 

Current Assets

2010

2009

 

 

 

Cash  and Cash Equivalents            

41,179,760

48,327,677

Accts.  Receivable  from  Related  Company

134,653,565

98,046,382

Short-term  Investment

8,736,014

1,656,319

Inventories                      

20,746,360

21,429,574

Other  Current  Assets                  

18,437,352

8,834,671

 

 

 

Total  Current  Assets                

223,753,051

178,294,623

 

Fixed Assets                  

 

260,066,073

 

170,427,505

 

Total  Assets                 

 

483,819,124

 

348,722,128

 


LIABILITIES & SHAREHOLDERS' EQUITY [BAHT]

 

Current Liabilities

2010

2009

 

 

 

Trade  Accts.  Payable

89,936,892

39,107,583

Other  Payable

46,435,144

50,494,632

Related  Companies  Payable

17,829,547

15,500,343

Accrued  Income  Tax

39,645,364

17,837,063

Accrued  Expenses

21,173,755

22,638,129

Other  Current  Liabilities             

3,889,032

3,650,223

 

 

 

Total Current Liabilities

218,909,734

149,227,973

 

Estimated Liabilities  for Employees’ Benefits

 

37,182,960

 

24,937,995

 

Total  Liabilities            

 

256,092,694

 

174,165,968

 

 

 

Shareholders' Equity

 

 

 

 

 

Share  capital : Baht  100  par  value 

  authorized,  issued  and  fully  paid  share 

  capital  80,000  shares

 

 

8,000,000

 

 

8,000,000

 

 

 

Capital  Paid                      

8,000,000

8,000,000

Retained  Earning

  Appropriated  for  Statutory  Reserve

 

800,000

 

800,000

  Unappropriated                   

218,926,430

165,756,160

 

Total Shareholders' Equity

 

227,726,430

 

174,556,160

 

Total Liabilities &  Shareholders'  Equity

 

483,819,124

 

348,722,128

 


                                                  

PROFIT & LOSS ACCOUNT

 

 Sale

2010

2009

 

 

 

Sales  Income                            

742,203,405

530,143,463

Gain  on Exchange Rate

2,804,940

469,021

Other  Income                 

2,603,481

7,153,554

 

Total  Sales                  

 

747,611,826

 

537,766,038

 

Expenses

 

 

 

 

 

Cost  of  Goods  Sold                  

564,148,327

426,051,542

Administrative Expenses

23,069,003

29,533,000

 

Total Expenses             

 

587,217,330

 

455,584,542

 

 

 

Profit / [Loss] before  Income  Tax

160,394,496

82,181,496

Income  Tax

[55,379,426]

[30,420,665]

 

 

 

Net  Profit / [Loss]

105,015,070

51,760,831

 

 

FINANCIAL ANALYSIS

 

ITEM

UNIT

2010

2009

 

 

 

 

LIQUIDITY RATIO

 

 

 

CURRENT RATIO

TIMES

1.02

1.19

QUICK RATIO

TIMES

0.84

0.99

 

 

 

 

ACTIVITY RATIO

 

 

 

FIXED ASSETS TURNOVER

TIMES

2.85

3.11

TOTAL ASSETS TURNOVER

TIMES

1.53

1.52

INVENTORY CONVERSION PERIOD

DAYS

13.42

18.36

INVENTORY TURNOVER

TIMES

27.19

19.88

RECEIVABLES CONVERSION PERIOD

DAYS

-

-

RECEIVABLES TURNOVER

TIMES

-

-

PAYABLES CONVERSION PERIOD

DAYS

58.19

33.50

CASH CONVERSION CYCLE

DAYS

(44.77)

(15.14)

 

 

 

 

PROFITABILITY RATIO

 

 

 

COST OF GOODS SOLD

%

76.01

80.37

SELLING & ADMINISTRATION

%

3.11

5.57

INTEREST

%

-

-

GROSS PROFIT MARGIN

%

24.72

21.07

NET PROFIT MARGIN BEFORE EX. ITEM

%

21.61

15.50

NET PROFIT MARGIN

%

14.15

9.76

RETURN ON EQUITY

%

46.11

29.65

RETURN ON ASSET

%

21.71

14.84

EARNING PER SHARE

BAHT

1,312.69

647.01

 

 

 

 

LEVERAGE RATIO

 

 

 

DEBT RATIO

TIMES

0.53

0.50

DEBT TO EQUITY RATIO

TIMES

1.12

1.00

TIME INTEREST EARNED

TIMES

-

-

 

 

 

 

ANNUAL GROWTH

 

 

 

SALES GROWTH

%

40.00

 

OPERATING PROFIT

%

95.17

 

NET PROFIT

%

102.89

 

FIXED ASSETS

%

52.60

 

TOTAL ASSETS

%

38.74

 

 

 

 

 

PROFITABILITY RATIO

 

Gross Profit Margin

24.72

Impressive

Industrial Average

21.96

Net Profit Margin

14.15

Impressive

Industrial Average

5.14

Return on Assets

21.71

Impressive

Industrial Average

7.32

Return on Equity

46.11

Impressive

Industrial Average

15.30

 

Gross Profit Margin used to assess a firm's financial health by revealing the proportion of money left over from sales after accounting for the cost of goods sold. Gross profit margin serves as the source for paying additional expenses and future savings. The company’s figure is 24.72%. When compared with the industry average, the ratio of the company was higher, this indicated that company was more profitable than the same industry.

 

Net Profit Margin is the indicator of the company's efficiency in that net profit takes into consideration all expenses of the company. A low profit margin indicates a low margin of safety, higher risk that a decline in sales will erase profits and result in a net loss. The company’s figure is   14.15% compared with those of its average competitors in the same industry, indicated that business was an efficient operator in a dominant position within its industry.

 

Return on Assets measures how efficiently profits are being generated from the assets employed in the business when compared with the ratios of firms in a similar business. A low ratio in comparison with industry averages indicates an inefficient use of business assets. Return on Assets ratio is 21.71%, higher figure when compared with those of its average competitors in the same industry, indicated that business was an efficient profit  in a dominant position within its industry.

 

Return on Equity indicates how profitable a company is by comparing its net income to its average shareholders' equity, ROE measures how much the shareholders earned for their investment in the company. Return on Equity ratio is 46.11%, higher figure when compared with those of its average competitors in the same industry, indicated that business was an efficient profit  in a dominant position within its industry.

 

Trend of the average competitors in the same industry for last 5 years

Return on Assets                       Uptrend

Return on Equity                        Uptrend

 


LIQUIDITY RATIO

 

Current Ratio

1.02

Acceptable

Industrial Average

1.58

Quick Ratio

0.84

 

 

 

Cash Conversion Cycle

(44.77)

 

 

 

 

The Current Ratio is to ascertain whether a company's short-term assets are readily available to pay off its short-term liabilities. The company's figure is 1.02 times in 2010, decreased from 1.19 times, then it is generally considered to have good short-term financial strength. When compared with the industry average, the ratio of the company was lower.

 

The Quick Ratio is a liquidity indicator that further refines the current ratio by measuring the amount of the most liquid current assets there are to cover current liabilities. The company's figure is 0.84 times in 2010, decreased from 0.99 times, by excluding inventory, the company may have problems meeting current liabilities.

 

The Cash Conversion Cycle measures the number of days a company's cash is tied up in the production and sales process of its operations and the benefit from payment terms from its creditors. It meant the company could survive when no cash inflow was received from sale for -45 days.

 

Trend of the average competitors in the same industry for last 5 years

Current Ratio                 Uptrend

 

 

 

 

LEVERAGE RATIO

 

Debt Ratio

0.53

Acceptable

Industrial Average

0.47

Debt to Equity Ratio

1.12

Risky

Industrial Average

0.95

Times Interest Earned

-

 

Industrial Average

5.40

 

Debt to Equity Ratio a measurement of how much suppliers, lenders, creditors and obligors have committed to the company versus what the shareholders have committed. A lower the percentage means that the company is using less leverage and has a stronger equity position.

 

Debt Ratio shows the proportion of a company's assets which are financed through debt. The company's figure is 0.53 greater than 0.5, most of the company's assets are financed through debt.

 

Trend of the average competitors in the same industry for last 5 years

Debt Ratio                                 Downtrend

Times Interest Earned                Uptrend

 

 

 

 

ACTIVITY RATIO

 

Fixed Assets Turnover

2.85

Satisfactory

Industrial Average

3.01

Total Assets Turnover

1.53

Impressive

Industrial Average

1.42

Inventory Conversion Period

13.42

 

 

 

Inventory Turnover

27.19

Impressive

Industrial Average

3.66

Receivables Conversion Period

-

 

 

 

Receivables Turnover

-

 

Industrial Average

2.77

Payables Conversion Period

58.19

 

 

 

 

Trend of the average competitors in the same industry for last 5 years

Fixed Assets Turnover                Downtrend

Total Assets Turnover                 Uptrend

Inventory Turnover                      Uptrend

Receivables Turnover                  Uptrend

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.16

UK Pound

1

Rs.81.79

Euro

1

Rs.68.34

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.